Nearly Complete Response of Brain Metastases from HER2 Overexpressing Breast Cancer with Lapatinib and Capecitabine after Whole Brain Irradiation

Trastuzumab treatment does not prevent intracranial seeding and is largely ineffective for established central nervous system metastasis in HER2 overexpressing breast cancer patients. Combination therapy of lapatinib and capecitabine may be an effective treatment option for brain metastasis of HER2-...

Full description

Saved in:
Bibliographic Details
Main Authors: Esin Oktay, Özlem Yersal, Nezih Meydan, Mehmet Sağıroğlu, Ömer Uyanık, Sabri Barutca
Format: Article
Language:English
Published: Wiley 2013-01-01
Series:Case Reports in Oncological Medicine
Online Access:http://dx.doi.org/10.1155/2013/234391
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832560318604115968
author Esin Oktay
Özlem Yersal
Nezih Meydan
Mehmet Sağıroğlu
Ömer Uyanık
Sabri Barutca
author_facet Esin Oktay
Özlem Yersal
Nezih Meydan
Mehmet Sağıroğlu
Ömer Uyanık
Sabri Barutca
author_sort Esin Oktay
collection DOAJ
description Trastuzumab treatment does not prevent intracranial seeding and is largely ineffective for established central nervous system metastasis in HER2 overexpressing breast cancer patients. Combination therapy of lapatinib and capecitabine may be an effective treatment option for brain metastasis of HER2-positive breast cancer. We report a patient with breast cancer overexpressing HER-2 where brain metastases were successfully treated with radiation and a combination of lapatinib and capecitabine.
format Article
id doaj-art-715e8daacfae4710be01f94c5b4b9b53
institution Kabale University
issn 2090-6706
2090-6714
language English
publishDate 2013-01-01
publisher Wiley
record_format Article
series Case Reports in Oncological Medicine
spelling doaj-art-715e8daacfae4710be01f94c5b4b9b532025-02-03T01:27:53ZengWileyCase Reports in Oncological Medicine2090-67062090-67142013-01-01201310.1155/2013/234391234391Nearly Complete Response of Brain Metastases from HER2 Overexpressing Breast Cancer with Lapatinib and Capecitabine after Whole Brain IrradiationEsin Oktay0Özlem Yersal1Nezih Meydan2Mehmet Sağıroğlu3Ömer Uyanık4Sabri Barutca5Department of Medical Oncology, Faculty of Medicine, Adnan Menderes University, 09010 Aydın, TurkeyDepartment of Medical Oncology, Faculty of Medicine, Adnan Menderes University, 09010 Aydın, TurkeyDepartment of Medical Oncology, Faculty of Medicine, Adnan Menderes University, 09010 Aydın, TurkeyDepartment of Medical Oncology, Faculty of Medicine, Adnan Menderes University, 09010 Aydın, TurkeyDepartment of Medical Oncology, Faculty of Medicine, Adnan Menderes University, 09010 Aydın, TurkeyDepartment of Medical Oncology, Faculty of Medicine, Adnan Menderes University, 09010 Aydın, TurkeyTrastuzumab treatment does not prevent intracranial seeding and is largely ineffective for established central nervous system metastasis in HER2 overexpressing breast cancer patients. Combination therapy of lapatinib and capecitabine may be an effective treatment option for brain metastasis of HER2-positive breast cancer. We report a patient with breast cancer overexpressing HER-2 where brain metastases were successfully treated with radiation and a combination of lapatinib and capecitabine.http://dx.doi.org/10.1155/2013/234391
spellingShingle Esin Oktay
Özlem Yersal
Nezih Meydan
Mehmet Sağıroğlu
Ömer Uyanık
Sabri Barutca
Nearly Complete Response of Brain Metastases from HER2 Overexpressing Breast Cancer with Lapatinib and Capecitabine after Whole Brain Irradiation
Case Reports in Oncological Medicine
title Nearly Complete Response of Brain Metastases from HER2 Overexpressing Breast Cancer with Lapatinib and Capecitabine after Whole Brain Irradiation
title_full Nearly Complete Response of Brain Metastases from HER2 Overexpressing Breast Cancer with Lapatinib and Capecitabine after Whole Brain Irradiation
title_fullStr Nearly Complete Response of Brain Metastases from HER2 Overexpressing Breast Cancer with Lapatinib and Capecitabine after Whole Brain Irradiation
title_full_unstemmed Nearly Complete Response of Brain Metastases from HER2 Overexpressing Breast Cancer with Lapatinib and Capecitabine after Whole Brain Irradiation
title_short Nearly Complete Response of Brain Metastases from HER2 Overexpressing Breast Cancer with Lapatinib and Capecitabine after Whole Brain Irradiation
title_sort nearly complete response of brain metastases from her2 overexpressing breast cancer with lapatinib and capecitabine after whole brain irradiation
url http://dx.doi.org/10.1155/2013/234391
work_keys_str_mv AT esinoktay nearlycompleteresponseofbrainmetastasesfromher2overexpressingbreastcancerwithlapatinibandcapecitabineafterwholebrainirradiation
AT ozlemyersal nearlycompleteresponseofbrainmetastasesfromher2overexpressingbreastcancerwithlapatinibandcapecitabineafterwholebrainirradiation
AT nezihmeydan nearlycompleteresponseofbrainmetastasesfromher2overexpressingbreastcancerwithlapatinibandcapecitabineafterwholebrainirradiation
AT mehmetsagıroglu nearlycompleteresponseofbrainmetastasesfromher2overexpressingbreastcancerwithlapatinibandcapecitabineafterwholebrainirradiation
AT omeruyanık nearlycompleteresponseofbrainmetastasesfromher2overexpressingbreastcancerwithlapatinibandcapecitabineafterwholebrainirradiation
AT sabribarutca nearlycompleteresponseofbrainmetastasesfromher2overexpressingbreastcancerwithlapatinibandcapecitabineafterwholebrainirradiation